A Phase 2, Randomized, Double-Blind, Placebo- Controlled Study to A ssess the Tolerability and Pharmacodynamic Effects of CRD-740, a PDE9 Inhibitor, in Participants with Chronic Heart Failure
This site uses cookies and third-party scripts to provide certain services. View Privacy Policy
